Total Funding
50
57
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43993
Aptatek is developing a biosensing platform for portable disease management devices.
- Tilla Worgall: Cofounder & Medical Advisor
- Michael Boyce-Jacino: CEO & PresidentPast Role: NetScientific PLC, COO
About the Company
Aptatek develops the diagnosis and monitoring of inborn diseases in centralized laboratories. Aptatek’s core technology is based on DNA aptamer sequences that detect small-molecule biomarkers and blood pressure. They can identify a large range of markers that are now only analyzed in a laboratory.
Women Founded
